Factors affecting the outcomes of intra-articular Corticosteroid injection in acute gouty ankle arthritis

Bui Thi Huong, Nguyen Thi Tra, Phung Duc Tam, Ngo Thi Thuc Nhan, Nguyen Vinh Ngoc

Main Article Content

Abstract

Intra-articular corticosteroid injection is an effective treatment for acute gouty ankle arthritis. However, treatment responses vary among patients. Our study included 34 patients with acute gouty ankle arthritis who received intra-articular corticosteroid injections. Factors influencing recurrence rates after corticosteroid injection were analyzed, including: personality characteristics, underlying disease, inflammatory markers, and metabolic disorders. Patients with dyslipidemia, elevated CRP-hs, and leukocytosis showed a negative linear correlation with improvement in VAS scores (p < 0.05). Patients with a leukocyte count > 10 G/L had a 7.8 times higher risk of gout recurrence compared to the non-leukocytosis group. Patients with CRP-hs ≥ 36.2 mg/L had a 2.7 times higher risk of recurrence after corticosteroid injection compared to the group with CRP-hs < 36.2 mg/L (OR = 2.7; p > 0.05). Evaluating the factors influencing treatment outcomes contributes to improving intervention effectiveness and reducing recurrence after intra-articular corticosteroid injections.

Article Details

References

1. Wu M, Liu FJ, Chen J, Chen L, Wei C, Hu ZM, et al. Prevalence and factors associated with bone erosion in patients with gout. Arthritis Care Res (Hoboken). 2019;71(12):1653–1659.
2. Ritterman SA, Fellars TA, Digiovanni CW. Current thoughts on ankle arthritis. R I Med J (2013). 2013 Mar 1; 96(3):30-3.
3. Brockett CL, Chapman GJ. Biomechanics of the ankle. Orthop Trauma. 2016 Jun; 30(3): 232-238.
4. Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). 2006; 65(10): 1312-24.
5. Fernandez C, Noguera R, Gonzalez J, Pascual E. Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide. J Rheumatol. 1999; 26(10): 2285-2286.
6. Liang J, Jiang Y, Huang Y, Huang Y, Liu F, Zhang Y, et al. Comorbidities and factors influencing frequent gout attacks in patients with gout: a cross-sectional study. Clin Rheumatol. 2021; 40: 2873-2880.
7. Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken). 2012; 64(10): 1447-1461.
8. Cole BJ, Schumacher HR Jr. Injectable corticosteroids in modern practice. J Am Acad Orthop Surg. 2005;13(1):37-46.
9. Naredo E, Rull M. Aspiration and injection of joints and periarticular tissue and intralesional therapy. Rheumatology: Elsevier; 2015. p. 542-53.